Related Experiment Video
Updated: Jun 18, 2026
16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.2K
Postmyocardial Infarction Ventricular Septal Defect Repair With Perioperative Impella 5.5 Support
Dina Al Rameni1, Toshinobu Kazui1, Kenneth Fox1
1Division of Cardiothoracic Surgery, Department of Surgery, University of Arizona College of Medicine-Tucson, Tucson, Arizona.
Annals of Thoracic Surgery Short Reports
|January 10, 2025
Summary
Ventricular septal defect (VSD) repair requires careful management of the Impella 5.5 device. This paper provides essential intraoperative tips to preserve the device, preventing complications during VSD surgery.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Mechanical Circulatory Support
Background:
- Ventricular septal defect (VSD) is a critical mechanical complication following myocardial infarction.
- VSD can precipitate rapid multiorgan system failure, necessitating urgent intervention.
- Mechanical circulatory support devices, such as the Impella 5.5, are crucial for patient stabilization.
Purpose of the Study:
- To highlight the importance of preserving the Impella 5.5 device during VSD repair surgery.
- To provide practical intraoperative strategies for protecting the Impella 5.5 during VSD repair.
- To minimize risks of device damage, thrombosis, and postoperative complications.
Main Methods:
- Review of clinical experience and established surgical techniques for VSD repair with Impella 5.5 support.
- Detailed description of intraoperative maneuvers to safeguard the device.
- Emphasis on meticulous handling and coordination between surgical and perfusion teams.
Main Results:
- Successful preservation of the Impella 5.5 device during VSD repair is achievable with careful technique.
- Adherence to recommended strategies can prevent device-related complications.
- Facilitates optimal end-organ perfusion and serves as a bridge to recovery.
Conclusions:
- Intraoperative preservation of the Impella 5.5 is paramount for successful VSD repair outcomes.
- Implementing specific technical tips can significantly reduce the incidence of device mishandling.
- This approach ensures continued hemodynamic support and improves patient prognosis.
More Related Videos
Related Concept Videos
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...